Category Archives: Irritable Bowel Syndrome

Updates to IBS Impact.com Main Website, December 2018

IBS Impact has recently completed the latest round of updates to many pages of our main website,  IBS Impact.com, The advocacy page,  IBS page, research page, IBS studies page, resources page ,and links page, plus the news updates in the blue and white footers of every page all have additions or updates of content or …

Continue reading

GERD Awareness Week: November 18-24, 2018

This week is GERD Awareness Week. Gastroesophageal reflux disease, like IBS, falls under the broad category of functional gastrointestinal and motility disorders, and many people with IBS also have GERD. According to former VeryWell.com IBS Guide IBS Guide Barbara Bradley Bolen, PhD,some studies show that up to 81% of people with IBS report some symptoms of GERD and vice versa, but that among those …

Continue reading

Veterans with IBS and Functional Gastrointestinal Disorders 2018

Today, November 11, is Veterans Day in the U.S. This year, as the date falls on a Sunday, it will be observed on Monday, November 12 as a federal holiday. It is also the traditional day on which many entities highlight veterans’ issues. U.S. veterans and current military service members who have been deployed in …

Continue reading

Congresswoman Eleanor Holmes Norton Co-Sponsors HR 1187 for Functional GI Research

According to IFFGD and the official Congressional legislative database Congress.gov, Congresswoman Eleanor Holmes Norton (D-DC-at large) is the latest member of the House of Representatives to sign on in October 2018 as a co-sponsor of the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2017. Congresswoman Norton is serving her fourteenth term representing, Washington, …

Continue reading

U.S. Food and Drug Administration Seeks Public Comment on Prucalopride for Chronic Idiopathic Constipation (CIC) and Tegaserod for Irritable Bowel Syndrome with Constipation (IBS-C) by October 16, 2018

UPDATE:  10/19/2018: The Gastrointestinal Drugs Advisory Committee voted to recommend approval of both of the medications under consideration below. This does not mean that the medications have the full approval of the FDA and can be made available yet. However, it is a positive step forward in the process toward full approval.   On Wednesday, …

Continue reading

IFFGD Virtual Advocacy Day, September 26, 2018, Needs U.S Citizens to Advocate for Functional GI Research

The International Foundation for Functional Gastrointestinal Disorders (IFFGD) has announced that Virtual Advocacy Day 2018 is coming soon on September 26, 2018. Virtual Advocacy Day is IFFGD’s annual day on which it encourages U.S. citizens to contact their members of the federal House of Representatives in support of the Functional Gastrointestinal and Motility Disorders Research …

Continue reading

Online Study: “Understanding IBS Patient Self-Management Strategies and their Relation to Outcomes”, Icahn-Mount Sinai, September 2018

The following study is currently seeking adults 18-65 years old who are fluent in English and have a diagnosis of IBS. The primary investigator is Laurie Keefer, PhD of Icahn Mount Sinai Medical School in New York, in cooperation with the Center for Psychosocial Research in GI at Northwestern University in Chicago. IBS Impact received …

Continue reading

American Neurogastroenterology and Motility Society Twitter Chat, “Hypnosis and GI Disorders”, August 20, 2018, 3:00-4:00 PM ET

The American Neurogastroenterology and Motility Society (ANMS) has announced that it will be holding a Twitter chat from 3:00-4:00 PM Eastern time, Monday, August 20, 2018 on the subject of “Hypnosis and GI Disorders.” The chat moderator will be Tiffany Taft, PhD,  Assistant Professor in the gastroenterology division of Northwestern University Feinberg School of Medicine, …

Continue reading

Online Study: Cognitive Mediators of Bowel Discomfort Validation Study, Swinburne University, Australia, June 2018

The following study currently seeking men and women at least 18 years old in any country with chronic gastrointestinal conditions is a followup to an online study posted here on August 12, 2017.  The 2017 study is now closed to new volunteers. The current study has received institutional ethical approval. All information available to IBS …

Continue reading

DNA Variants on Chromosome 9 Appear To Be Associated With Irritable Bowel Syndrome (IBS) in Some Women

In April 2018, the journal Gastroenterology published an article that an international collaboration of researchers headed by the Karolinska Institutet in Sweden, has identified several DNA variants on Chromosome 9 that may be associated with higher risk of IBS in women, particularly IBS with constipation. This possible correlation was not found in men. The identified …

Continue reading